JEŠETA, Michal, Anna POSPÍŠILOVÁ, Lenka MEKIŇOVÁ, Kateřina FRANZOVÁ, Pavel VENTRUBA, Eva LOUSOVÁ, Bartosz KEMPISTY, Tomáš OŽDIAN, Jana ŽÁKOVÁ and Igor CRHA. Non-Invasive Diagnostics of Male Spermatogenesis from Seminal Plasma: Seminal Proteins. Diagnostics. Basel: MDPI, 2023, vol. 13, No 15, p. 1-15. ISSN 2075-4418. Available from: https://dx.doi.org/10.3390/diagnostics13152468.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Non-Invasive Diagnostics of Male Spermatogenesis from Seminal Plasma: Seminal Proteins
Authors JEŠETA, Michal (203 Czech Republic, belonging to the institution), Anna POSPÍŠILOVÁ (203 Czech Republic, belonging to the institution), Lenka MEKIŇOVÁ (703 Slovakia, belonging to the institution), Kateřina FRANZOVÁ (203 Czech Republic, belonging to the institution), Pavel VENTRUBA (203 Czech Republic, belonging to the institution), Eva LOUSOVÁ (203 Czech Republic, belonging to the institution), Bartosz KEMPISTY (616 Poland), Tomáš OŽDIAN (203 Czech Republic), Jana ŽÁKOVÁ (203 Czech Republic, belonging to the institution) and Igor CRHA (203 Czech Republic, belonging to the institution).
Edition Diagnostics, Basel, MDPI, 2023, 2075-4418.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30214 Obstetrics and gynaecology
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 3.600 in 2022
RIV identification code RIV/00216224:14110/23:00131350
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.3390/diagnostics13152468
UT WoS 001045385400001
Keywords in English spermatozoa; azoospermia; sperm isolation; sperm analyses
Tags 14110240, 14110611, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 4/3/2024 09:59.
Abstract
The compounds of seminal plasma have great potential as biomarkers of male fertility and can be used as a diagnostic tool for types of azoospermia. Azoospermia occurs in approximately 1% of the male population, and for an effective therapy of this form of male infertility, it is important to distinguish between obstructive and non-obstructive azoospermia. Proteins in seminal plasma can serve as biomarkers for diagnosing azoospermia. Considering the various types of obstructions, a combination of multiple proteins is advisable for diagnostic purposes. In this context, testicular and epididymal proteins are particularly significant, as they are specific to these tissues and typically absent in ejaculate during most obstructions. A combination of multiple biomarkers is more effective than the analysis of a single protein. This group of markers contains TEX101 and ECM1 proteins, combined detections of these two bring a diagnostic output with a high sensitivity and specificity. Similar results were observed for combined detection of TEX101 and SPAG1. The effective using of specific biomarkers from seminal plasma can significantly improve the existing approaches to diagnosis of the causes of male infertility.
PrintDisplayed: 22/7/2024 16:29